Adtalem Global Education (NYSE:CVSA) SVP Sells $614,676.06 in Stock

Adtalem Global Education Inc. (NYSE:CVSA) SVP Douglas Beck sold 4,526 shares of the firm’s stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $135.81, for a total value of $614,676.06. Following the completion of the sale, the senior vice president owned 28,544 shares in the company, valued at approximately $3,876,560.64. This represents a 13.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Price Performance

Shares of Adtalem Global Education stock opened at $132.20 on Friday. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.45. Adtalem Global Education Inc. has a 1-year low of $86.97 and a 1-year high of $156.26. The firm’s fifty day simple moving average is $125.16. The company has a market cap of $4.50 billion, a P/E ratio of 18.78, a P/E/G ratio of 0.95 and a beta of 0.62.

Adtalem Global Education (NYSE:CVSA) last issued its quarterly earnings results on Thursday, August 6th. The company reported $2.09 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.19. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.The company had revenue of $501.38 million for the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. On average, research analysts expect that Adtalem Global Education Inc. will post 8.99 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Adtalem Global Education stock. Kendall Capital Management purchased a new position in Adtalem Global Education Inc. (NYSE:CVSA) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 11,622 shares of the company’s stock, valued at approximately $1,449,000. 98.84% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Weiss Ratings reissued a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Friday, May 22nd. Barrington Research reiterated an “outperform” rating and issued a $170.00 price objective on shares of Adtalem Global Education in a report on Monday, June 8th. Truist Financial raised their price objective on shares of Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, May 11th. Finally, Wall Street Zen raised Adtalem Global Education from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $155.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.